Total Payments
$4,486
2024 Payments
$525.81
Companies
29
Transactions
149
Medicare Patients
6,760
Medicare Billing
$1.5M
Payment Breakdown by Category
Food & Beverage$3,936 (87.7%)
Research$450.00 (10.0%)
Education$99.99 (2.2%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,936 | 147 | 87.7% |
| Unspecified | $450.00 | 1 | 10.0% |
| Education | $99.99 | 1 | 2.2% |
Payments by Type
General
$4,036
148 transactions
Research
$450.00
1 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $506.58 | 22 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $466.67 | 20 | $0 (2024) |
| Midmark Corporation | $450.00 | 1 | $0 (2017) |
| Allergan, Inc. | $414.89 | 5 | $0 (2020) |
| Janssen Pharmaceuticals, Inc | $367.66 | 10 | $0 (2024) |
| PFIZER INC. | $318.99 | 16 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $312.52 | 14 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $276.77 | 11 | $0 (2022) |
| AbbVie Inc. | $232.82 | 11 | $0 (2021) |
| Lilly USA, LLC | $200.93 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $525.81 | 23 | Novartis Pharmaceuticals Corporation ($133.38) |
| 2023 | $632.35 | 23 | Amgen Inc. ($191.38) |
| 2022 | $597.97 | 30 | Novartis Pharmaceuticals Corporation ($149.84) |
| 2021 | $746.81 | 33 | AbbVie Inc. ($216.11) |
| 2020 | $486.22 | 17 | Cardiovascular Systems Inc. ($111.11) |
| 2019 | $431.48 | 13 | Janssen Pharmaceuticals, Inc ($147.51) |
| 2018 | $399.92 | 4 | Allergan Inc. ($372.68) |
| 2017 | $664.99 | 6 | Midmark Corporation ($450.00) |
All Payment Transactions
149 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/05/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $30.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 12/04/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.25 | General |
| Category: Gastroenterology | ||||||
| 12/03/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $23.02 | General |
| Category: Inflammation | ||||||
| 11/19/2024 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Neuroscience | ||||||
| 11/15/2024 | Azurity Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $19.61 | General |
| 11/12/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $22.85 | General |
| Category: Respiratory | ||||||
| 11/07/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.12 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $23.25 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 10/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $29.09 | General |
| 09/19/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $28.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/12/2024 | Braeburn Inc. | BRIXADI (Drug) | Food and Beverage | In-kind items and services | $19.73 | General |
| Category: Opioid Use Disorder | ||||||
| 09/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.87 | General |
| Category: Inflammation | ||||||
| 07/09/2024 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $24.95 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 06/26/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $4.60 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/20/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $30.95 | General |
| Category: Diabetes | ||||||
| 06/04/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: Inflammation | ||||||
| 05/30/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $22.74 | General |
| Category: Gastroenterology | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 04/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $14.02 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/20/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $16.13 | General |
| Category: Gastroenterology | ||||||
| 03/05/2024 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $15.65 | General |
| 01/31/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.83 | General |
| Category: Gastroenterology | ||||||
| 12/11/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $24.36 | General |
| Category: Gastroenterology | ||||||
| 11/21/2023 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Gastroenterology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 14 | 1,671 | 4,268 | $1.3M | $391,802 |
| 2022 | 16 | 1,930 | 5,173 | $1.6M | $444,290 |
| 2021 | 18 | 1,676 | 3,960 | $1.2M | $342,195 |
| 2020 | 14 | 1,483 | 3,988 | $1.2M | $338,815 |
Total Patients
6,760
Total Services
17,389
Medicare Billing
$1.5M
Procedure Codes
64
All Medicare Procedures & Services
64 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 203 | 1,143 | $343,200 | $115,979 | 33.8% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 428 | 1,675 | $418,750 | $113,285 | 27.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 284 | 353 | $158,850 | $52,226 | 32.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 315 | 420 | $189,000 | $41,350 | 21.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 126 | 345 | $86,300 | $35,984 | 41.7% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 124 | 138 | $55,200 | $15,335 | 27.8% |
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 36 | 37 | $14,800 | $5,805 | 39.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $6,600 | $3,153 | 47.8% |
| 99497 | Advance care planning, first 30 minutes | Facility | 2023 | 45 | 46 | $13,800 | $2,978 | 21.6% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $4,550 | $1,891 | 41.6% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 13 | 14 | $3,500 | $1,547 | 44.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 14 | 14 | $6,300 | $1,460 | 23.2% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 23 | 23 | $1,150 | $485.07 | 42.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 25 | 25 | $1,875 | $323.25 | 17.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 510 | 2,319 | $579,750 | $141,285 | 24.4% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 204 | 1,122 | $336,600 | $98,499 | 29.3% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 329 | 430 | $193,500 | $73,058 | 37.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 345 | 469 | $211,050 | $42,646 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 113 | 299 | $74,750 | $33,192 | 44.4% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 118 | 122 | $48,800 | $14,019 | 28.7% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Office | 2022 | 55 | 60 | $24,000 | $8,542 | 35.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 44 | 44 | $13,200 | $6,470 | 49.0% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Office | 2022 | 28 | 41 | $12,300 | $4,587 | 37.3% |
| 99310 | Follow-up nursing facility visit per day, typically 35 minutes | Facility | 2022 | 23 | 33 | $9,900 | $3,793 | 38.3% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 23 | 24 | $9,600 | $3,381 | 35.2% |
About Dr. David Lalezari, MD
Dr. David Lalezari, MD is a Internal Medicine healthcare provider based in West Hollywood, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/16/2011. The National Provider Identifier (NPI) number assigned to this provider is 1093094427.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Lalezari, MD has received a total of $4,486 in payments from pharmaceutical and medical device companies, with $525.81 received in 2024. These payments were reported across 149 transactions from 29 companies. The most common payment nature is "Food and Beverage" ($3,936).
As a Medicare-enrolled provider, Lalezari has provided services to 6,760 Medicare beneficiaries, totaling 17,389 services with total Medicare billing of $1.5M. Data is available for 4 years (2020–2023), covering 64 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location West Hollywood, CA
- Active Since 08/16/2011
- Last Updated 01/09/2025
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1093094427
Products in Payments
- ELIQUIS (Drug) $595.76
- Otezla (Drug) $412.86
- XARELTO (Drug) $343.12
- XIFAXAN (Drug) $312.52
- LEQVIO (Drug) $258.05
- BOTOX - NEUROLOGY (Drug) $228.61
- UBRELVY (Drug) $225.65
- ENTRESTO (Drug) $208.62
- MOUNJARO (Drug) $152.92
- BOTOX (Biological) $144.07
- AJOVY (Drug) $130.03
- Peripheral Orbital Atherectomy System (Device) $111.11
- MYRBETRIQ (Drug) $89.30
- Repatha (Biological) $72.49
- BREZTRI (Drug) $46.04
- Da Vinci Surgical System (Device) $37.53
- Dayvigo (Drug) $36.41
- NURTEC ODT (Drug) $35.54
- DIFICID (Drug) $32.31
- Orbactiv (Drug) $29.29
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in West Hollywood
Anthony Mills, Md, MD
Internal Medicine — Payments: $510,976
Internal Medicine $510,976
Dr. Andrew Hendifar, Md, Mph, MD, MPH
Internal Medicine — Payments: $290,268
Internal Medicine $290,268
Dr. Michael Shehata, M.d, M.D
Internal Medicine — Payments: $279,189
Internal Medicine $279,189
Dr. Stanley Jordan, Md, MD
Internal Medicine — Payments: $201,443
Internal Medicine $201,443
Dr. Barham Abu Dayyeh, Md, MD
Internal Medicine — Payments: $173,790
Internal Medicine $173,790
Dr. Rabindra Watson, M.d, M.D
Internal Medicine — Payments: $157,237
Internal Medicine $157,237